Clinical Trials Directory

Trials / Completed

CompletedNCT04649918

Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19

Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 - an Observational Trial

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Schön Klinik Berchtesgadener Land · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

As a direct consequence of the COVID-19 pandemic, it is assumed that the number of patients with COVID-19-related disabilities will increase significantly. Patients with mild, severe, and critical forms of the disease show long-term sequelae in different systems (respiratory, muscular, psychological, cognitive etc.). Persistent dyspnea is a frequently described symptom after the acute phase of the disease. Coupled with reduced oxygen saturation, an increased risk of developing lung fibrosis has been observed. Specialized rehabilitation medicine (e.g. pulmonary rehabilitation) might counteract these long-term consequences and therefore seems to be a promising approach to treat long-term COVID-19 consequences. Further, there is scarce evidence about COVID-19 specific rehabilitation contents. It was suggested to use treatment regimes in analogy to patients with idiopathic pulmonary fibrosis. There is evidence that pulmonary rehabilitation improves physical performance, quality of life and reduces anxiety and depression symptoms in patients with idiopathic pulmonary fibrosis and other chronic respiratory diseases. Since impairments related to idiopathic pulmonary fibrosis also play an important role in COVID-19, the aim of this study is to evaluate the short and medium-term effects of a standardized 3-week pulmonary rehabilitation program. The results will be analyzed within the two cohorts (mild/moderate and severe/critical COVID 19) as well as between the two cohorts for the primary outcome. Furthermore, the effects of pulmonary rehabilitation will be compared with a retrospective cohort of idiopathic pulmonary fibrosis.

Conditions

Interventions

TypeNameDescription
OTHERpulmonary rehabilitationCOVID 19 patients perform a standardized 3-week inpatient pulmonary rehabilitation program

Timeline

Start date
2020-11-25
Primary completion
2021-01-16
Completion
2021-01-16
First posted
2020-12-02
Last updated
2021-12-23

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04649918. Inclusion in this directory is not an endorsement.